187 related articles for article (PubMed ID: 17097207)
1. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis.
Tokuda E; Watanabe S; Okawa E; Ono S
Neurotherapeutics; 2015 Apr; 12(2):461-76. PubMed ID: 25761970
[TBL] [Abstract][Full Text] [Related]
5. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins.
Puttaparthi K; Gitomer WL; Krishnan U; Son M; Rajendran B; Elliott JL
J Neurosci; 2002 Oct; 22(20):8790-6. PubMed ID: 12388585
[TBL] [Abstract][Full Text] [Related]
6. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner.
Nagano S; Satoh M; Sumi H; Fujimura H; Tohyama C; Yanagihara T; Sakoda S
Eur J Neurosci; 2001 Apr; 13(7):1363-70. PubMed ID: 11298796
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of metallothionein-I mRNA expression in a rodent model for amyotrophic lateral sclerosis.
Ono S; Endo Y; Tokuda E; Ishige K; Tabata K; Asami S; Ito Y; Suzuki T
Biol Trace Elem Res; 2006 Oct; 113(1):93-104. PubMed ID: 17114818
[TBL] [Abstract][Full Text] [Related]
8. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
[TBL] [Abstract][Full Text] [Related]
9. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.
Lelie HL; Liba A; Bourassa MW; Chattopadhyay M; Chan PK; Gralla EB; Miller LM; Borchelt DR; Valentine JS; Whitelegge JP
J Biol Chem; 2011 Jan; 286(4):2795-806. PubMed ID: 21068388
[TBL] [Abstract][Full Text] [Related]
10. Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Exp Neurol; 2008 Sep; 213(1):122-8. PubMed ID: 18617166
[TBL] [Abstract][Full Text] [Related]
11. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
[TBL] [Abstract][Full Text] [Related]
12. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
13. Zinc in the spinal cord of a mutant SOD1 mouse model of ALS.
Pamphlett R; Kum-Jew S
Neuroreport; 2003 Mar; 14(4):547-9. PubMed ID: 12657882
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis.
Tokuda E; Okawa E; Ono S
J Neurochem; 2009 Oct; 111(1):181-91. PubMed ID: 19656261
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice.
Ignacio S; Moore DH; Smith AP; Lee NM
Ann N Y Acad Sci; 2005 Aug; 1053():121-36. PubMed ID: 16179515
[TBL] [Abstract][Full Text] [Related]
16. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of metallothionein protects cultured motor neurons against oxidative stress, but not mutant Cu/Zn-superoxide dismutase toxicity.
Taylor DM; Minotti S; Agar JN; Durham HD
Neurotoxicology; 2004 Sep; 25(5):779-92. PubMed ID: 15288509
[TBL] [Abstract][Full Text] [Related]
18. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
19. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
20. Progressive decrease in the level of YAPdeltaCs, prosurvival isoforms of YAP, in the spinal cord of transgenic mouse carrying a mutant SOD1 gene.
Morimoto N; Nagai M; Miyazaki K; Kurata T; Takehisa Y; Ikeda Y; Kamiya T; Okazawa H; Abe K
J Neurosci Res; 2009 Mar; 87(4):928-36. PubMed ID: 18951500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
